Annual ROE
-19.52%
-57.39%-151.54%
December 31, 2023
Summary
- As of February 7, 2025, NGNE annual return on equity is -19.52%, with the most recent change of -57.39% (-151.54%) on December 31, 2023.
- During the last 3 years, NGNE annual ROE has fallen by -74.50% (-135.50%).
- NGNE annual ROE is now -135.50% below its all-time high of 54.98%, reached on December 1, 2021.
Performance
NGNE ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-32.81%
+25.14%+43.38%
September 30, 2024
Summary
- As of February 7, 2025, NGNE quarterly return on equity is -32.81%, with the most recent change of +25.14% (+43.38%) on September 30, 2024.
- Over the past year, NGNE quarterly ROE has dropped by -54.78% (-249.34%).
- NGNE quarterly ROE is now -150.06% below its all-time high of 65.54%, reached on December 31, 2023.
Performance
NGNE Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
NGNE ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -151.5% | -249.3% |
| 3 y3 years | -135.5% | - |
| 5 y5 years | -135.5% | - |
NGNE ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -135.5% | at low | -150.1% | +99.1% |
| 5 y | 5-year | -135.5% | at low | -150.1% | +99.1% |
| alltime | all time | -135.5% | at low | -150.1% | +99.1% |
Neurogene ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -32.81%(-43.4%) |
| Jun 2024 | - | -57.95%(-98.4%) |
| Mar 2024 | - | -3610.93%(-5609.5%) |
| Dec 2023 | -19.52% | 65.54%(+198.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | 21.97%(+54.0%) |
| Jun 2023 | - | 14.27% |
| Dec 2022 | 37.87%(-31.1%) | - |
| Dec 2021 | 54.98% | - |
FAQ
- What is Neurogene annual return on equity?
- What is the all time high annual ROE for Neurogene?
- What is Neurogene annual ROE year-on-year change?
- What is Neurogene quarterly return on equity?
- What is the all time high quarterly ROE for Neurogene?
- What is Neurogene quarterly ROE year-on-year change?
What is Neurogene annual return on equity?
The current annual ROE of NGNE is -19.52%
What is the all time high annual ROE for Neurogene?
Neurogene all-time high annual return on equity is 54.98%
What is Neurogene annual ROE year-on-year change?
Over the past year, NGNE annual return on equity has changed by -57.39% (-151.54%)
What is Neurogene quarterly return on equity?
The current quarterly ROE of NGNE is -32.81%
What is the all time high quarterly ROE for Neurogene?
Neurogene all-time high quarterly return on equity is 65.54%
What is Neurogene quarterly ROE year-on-year change?
Over the past year, NGNE quarterly return on equity has changed by -54.78% (-249.34%)